Ulthera Appoints Greg Waller as CFO

Ulthera, a global commercial-stage medical device company, has named Greg Waller as chief financial officer (CFO), a newly created position. Waller’s 35 years of experience showcases a solid track record of strategic financial growth for both privately held and publically traded companies.

Most recently, Waller served as CFO of Universal Building Products, a manufacturer of concrete construction accessories. Prior to that, he held several leadership positions at Sybron Dental Specialties, a manufacturer and marketer of consumable dental products. During his 25-year tenure with Sybron, he was instrumental in the initial public offering (IPO) of the company and in more than 30 company acquisitions worldwide. He also played a pivotal role in supporting the growth of the company from 100 to more than 4,000 employees and from US$10m to more than US$750m in sales.

Waller currently serves as a board member and audit committee chairman for Endologix and as a board member for Sunshine Heart. Additionally, he previously served as board member and audit committee chairman for Alsius, Biolase, Cardiogenesis, Clarient and SenoRx, all publicly traded companies.


Related reading

New consumer banking head for Citi Asia Pacific